Quarterly report pursuant to Section 13 or 15(d)

Acquisitions (Details Textual)

v3.5.0.2
Acquisitions (Details Textual) - USD ($)
3 Months Ended 9 Months Ended
Mar. 07, 2016
Sep. 30, 2016
Sep. 30, 2015
Sep. 30, 2016
Sep. 30, 2015
Stock Issued During Period, Value, New Issues       $ 668,437  
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Total   $ (3,376,662) $ (1,355,536) (9,642,376) $ (5,697,975)
Forfeiture of Holdback Shares from the Jade Acquisition Value       0  
Jade Therapeutics, Inc [Member]          
Business Acquisition, Percentage of Voting Interests Acquired 100.00%        
Business Combination, Consideration Transferred, Liabilities Incurred       $ 300,000  
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares       765,728  
Percentage Of Common Stock Issued       90.00%  
Percentage Of Common Stock To Be Issued       10.00%  
Business Combination, Contingent Consideration, Liability   $ 2,164,451   $ 2,164,451  
Stock Issued During Period, Value, New Issues       $ 2,910,000  
Business Acquisition, Share Price   $ 3.80   $ 3.80  
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents   $ 186,000   $ 186,000  
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets   369,000   369,000  
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Total       $ 384,000  
Finite-Lived Intangible Asset, Useful Life       3 years  
Business Combination, Acquisition Related Costs       $ 300,000  
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables   46,000   46,000  
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-term Debt   $ 232,457   232,457  
Business Combination Contigent Consideration       1,210,000  
Forfeiture of Holdback Shares from the Jade Acquisition Value $ 205,207        
Jade Therapeutics, Inc [Member] | Selling, General and Administrative Expenses [Member]          
Business Combination,increase decrease in Liability       $ 300,000